Clinical Trial Update: Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating resveratrol's impact on inflammation in patients with Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: University of Turin, Italy | Conditions: Type 2 Diabetes Mellitus, Inflammation | Phase 3 | Status: COMPLETED